Zivo BioscienceZIVO
13F holders, Q2 2025 (June 30)2holders +1
2new positions
0sold out
$13.53avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding Zivo Bioscience Inc. (ZIVO) in their 13F filings, up 1 from Q4 2024. 2 opened new positions and 0 sold out. The largest holders were CoreCap Advisors, LLC ($59K) and Huntington National Bank ($2K).
- Company
- Zivo Bioscience Inc.
- CUSIP
- 98978N309
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $60K |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q2 2025: 4,464 shares bought, net +4,464 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| CoreCap Advisors, LLC | 0.00% | New | 4,360 | $59K |
| Huntington National Bank | 0.00% | New | 104 | $2K |
"% of holder's portfolio" is ZIVO's weight in each manager's 13F, not the share of Zivo Bioscience Inc. the manager owns.